FDA launches new priority review voucher program for select biopharmas

Juvena Therapeutics

A colorful variation and collection of international currency a global business money exchange and finance
Biotech

US may be ending grants for biotechs with foreign investors

HHS is allegedly canceling clinical trial funding for biotechs with ties to certain foreign investors, Fierce Biotech has learned.
Gabrielle Masson Jun 18, 2025 11:50am